Delta-What? Deciphering the World of Cannabinoids

Area of Science:

• Pharmacology
• Cannabinoid Science
• Medicinal Chemistry

Background:

• Cannabis contains over 400 chemicals, including Delta-9-tetrahydrocannabinol (D9-THC), responsible for psychoactive effects.
• Chemical modifications and synthetic compounds create alternative cannabinoids, expanding the market.
• The growing popularity of these cannabinoids coincides with cannabis legalization in the U.S.

Purpose of the Study:

• To identify commonly used alternative cannabinoids.
• To examine the complex legal landscape surrounding these compounds.
• To summarize existing literature on the clinical effects of alternative cannabinoids.

Main Methods:

• Literature review of scientific databases.
• Analysis of legal statutes and regulatory documents.
• Synthesis of clinical data from published studies.

Main Results:

• Identification of prevalent alternative cannabinoids and their chemical origins.
• Overview of the varying and often ambiguous legal classifications.
• Summary of reported clinical effects, including efficacy and adverse events.

Conclusions:

• Healthcare providers must be aware of the diverse range of cannabinoid products and their distinct properties.
• Understanding alternative cannabinoids is crucial for informed patient care and risk assessment.
• Further research is needed to fully elucidate the safety and efficacy profiles of these compounds.